T1R2

Price range: $20.00 through $268.00

T1R2 5mg / 10mg / 15mg / 20mg / 30mg / 40mg / 50mg / 60mg / 100mg / 120mg


What is T1R2

Tirzepatide is supplied strictly for laboratory research and analytical applications, commonly referenced in metabolic pathway and receptor signaling studies.

Specifications:
  • Format: Lyophilized powder
  • Category: Fat Loss & Metabolism
  • Documentation: COA available

Research Use Only — Not for Human Consumption.

SKU: N/A Category:

Description

  • About Tirzepatide (Mounjaro® active ingredient)

    Tirzepatide — the active peptide in Mounjaro® (CAS 2023788-19-2) — is a first-in-class dual GIP/GLP-1 receptor agonist (the "twincretin") with a C20 fatty diacid chain enabling albumin binding and once-weekly dosing pharmacokinetics (~5-day half-life). It co-activates both the glucose-dependent insulinotropic polypeptide receptor (GIPR) and the glucagon-like peptide-1 receptor (GLP-1R), producing additive or synergistic effects on insulin secretion and energy homeostasis compared to selective GLP-1R agonists. Used in research to dissect the relative contributions of GIP and GLP-1 signaling in metabolic regulation, β-cell function, and CNS appetite pathways. Supplied as lyophilized peptide for non-clinical research use only. Internal catalog code: VE-TIRZ.

    COMMON RESEARCH APPLICATIONS

    Dual GIP/GLP-1 Receptor Pharmacology
    Tirzepatide activates both GIPR and GLP-1R with balanced potency. Used to compare dual vs. selective agonism in cAMP signaling, β-arrestin recruitment, and receptor internalization in HEK293 cell models co-expressing GIPR and GLP-1R.

    β-Cell Function Research
    Tool compound for studying augmented insulin secretion through dual incretin receptor activation in INS-1 and MIN6 pancreatic β-cell models; distinguishing GIP vs. GLP-1 contribution at different glucose concentrations.

    Metabolic & Adipose Tissue Studies
    GIPR activation in adipose tissue drives lipolysis modulation; used to study fat depot dynamics, FFA flux, and lipid metabolism in adipocyte cell models alongside GLP-1R-driven CNS effects.

    Comparative GLP-1R Agonist Benchmarking
    Reference standard for comparing dual GIPR/GLP-1R agonism vs. selective GLP-1R agonists (semaglutide) and triple agonists (retatrutide) in the same experimental system.

  • Chemical Identity

    Compound Name: Tirzepatide

    Synonyms: Mounjaro active ingredient · LY3298176 · GIP/GLP-1 dual agonist · twincretin

    CAS Number: 2023788-19-2

    EC Number: N/A (synthetic peptide)

    Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈S

    Molecular Weight: 4813.50 g/mol

    Internal Catalog Code: VE-TIRZ

    Physical Properties

    Appearance: White to off-white lyophilized powder

    Solubility (water): ~1 mg/mL in sterile water or PBS (pH 7.4)

    Solubility (organic): Soluble in DMSO (~5 mg/mL)

    Hygroscopic: Yes — store desiccated

    Quality & Testing

    Purity: ≥98% (HPLC)

    Testing Method : Reverse-phase HPLC · MS confirmation · sequence verification

    Verification

    COA: Lot-specific, included with order (QR on label)

    SDS Supplier : See SDS/MSDS · OSHA HCS / GHS compliant

    Handling & Storage

    Storage Temperature: Store desiccated at −20°C long-term; 2–8°C short-term. Protect from light. Refer to SDS/COA for compound-specific handling.

    Light Sensitivity: Protect from light

    Reconstitution: Dissolve in sterile water or PBS (pH 7.4); avoid repeated freeze-thaw cycles

    Available Strengths: 5 mg · 10 mg · 15 mg · 20 mg · 30 mg · 40 mg · 50 mg · 60 mg · 120 mg

    SKU (5 mg): VE-TIRZ-005

    SKU (10 mg): VE-TIRZ-010

    SKU (15 mg): VE-TIRZ-015

    SKU (20 mg): VE-TIRZ-020

    SKU (30 mg): VE-TIRZ-030

    SKU (40 mg): VE-TIRZ-040

    SKU (50 mg): VE-TIRZ-050

    SKU (60 mg): VE-TIRZ-060

    SKU (120 mg): VE-TIRZ-120

    • What is this product?
      Tirzepatide (VE-TIRZ) is supplied as a lyophilized dual GIP/GLP-1 receptor agonist peptide (CAS 2023788-19-2, MW 4813.50 g/mol) intended for laboratory research use only. It is the active peptide in Mounjaro® and Zepbound®.
    • What purity and testing methods are used?
      Each lot is tested by reverse-phase HPLC and MS confirmation to ≥98% purity. A lot-specific COA is included with every order. Scan the QR code on the label to access your lot documentation.
    • What are the key chemical identifiers?
      CAS 2023788-19-2 · Molecular formula C₂₂₅H₃₄₈N₄₈O₆₈S · MW 4813.50 g/mol · Synonyms: LY3298176, Mounjaro active ingredient, GIP/GLP-1 dual agonist, twincretin.
    • How is tirzepatide reconstituted for research use?
      Dissolve in sterile water or PBS (pH 7.4) at ~1 mg/mL. DMSO (~5 mg/mL) is suitable for organic applications. Store desiccated at −20°C long-term. Avoid repeated freeze-thaw cycles. Protect from light.
    • How does tirzepatide differ from semaglutide in research applications?
      Semaglutide selectively activates GLP-1R; tirzepatide co-activates both GLP-1R and GIPR. This dual mechanism makes tirzepatide useful for studies comparing incretin receptor contributions and for benchmarking downstream signaling differences in the same cell model.
    • What is the recommended storage upon receipt?
      Store immediately at −20°C in a desiccated environment upon receipt. Short-term at 2–8°C is acceptable. Do not leave at room temperature. Inspect the vial for integrity and contact support if damaged.
    • What is a COA and why does it matter?
      A COA documents lot-specific analytical results including purity (HPLC ≥98%), identity (MS confirmation), and appearance. Each VE-TIRZ lot ships with a QR-accessible COA. Review before use to confirm identity and purity meet your experimental requirements.

Additional information

Dosage

100mg, 10mg, 120mg, 15mg, 20mg, 30mg, 40mg, 50mg, 5mg, 60mg

Reviews

There are no reviews yet.

Be the first to review “T1R2”

Your email address will not be published. Required fields are marked *